Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Podcasts
Resources
Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
breast cancer diagnostics
MedTech
ASCO: HER2 diagnostics need a revolution after Enhertu data
“Pathologists have a hard time distinguishing between” IHC 0 and IHC 1+ HER2 expression on existing assays, said MD Anderson's Debu Tripathy.
Angus Liu
Jun 6, 2022 11:11am
Paige nets European OK for AI to spot prostate cancer biomarkers
May 12, 2022 3:06pm
Illumina outlines future long-read chemistry, posts sales record
Jan 10, 2022 6:13pm
AI developer Paige scores CE marks in breast, prostate cancers
Dec 14, 2020 7:26am
Breast cancer study uncovers new RNA targets for treatment
Oct 19, 2020 8:55am
Imperial, University of Leicester tap Natera for breast cancer study
Nov 1, 2017 11:55am
